- Report
- July 2023
- 220 Pages
Global
From €1911EUR$1,990USD£1,646GBP
- Report
- March 2022
- 140 Pages
Global
From €1911EUR$1,990USD£1,646GBP
Avandia is a drug used to treat type 2 diabetes, a condition in which the body does not produce enough insulin or does not use insulin properly. It belongs to a class of drugs known as thiazolidinediones, which work by increasing the body's sensitivity to insulin. Avandia is used to help control blood sugar levels in people with type 2 diabetes. It is also used to reduce the risk of heart attack and stroke in people with type 2 diabetes who have already had a heart attack or stroke.
Avandia is part of the Endocrine and Metabolic Disorders Drugs market, which includes drugs used to treat conditions such as diabetes, thyroid disorders, and obesity. These drugs are used to help control blood sugar levels, reduce the risk of heart attack and stroke, and manage other metabolic disorders.
Companies in the Avandia market include GlaxoSmithKline, Merck, Sanofi, Novo Nordisk, and Eli Lilly. Show Less Read more